Science and Research committee  It was without question a very challenging time in the early 2000s, as global pharmaceutical companies restructured their research enterprise. A number of organizations, like one of our predecessor organizations, grew out of that. We took over and acquired the research hub of a g

Science and Research committee  There are quite a few extraordinary examples. If you look at AbCellera in Vancouver, Precision NanoSystems in Vancouver, Biovectra in Atlantic Canada, J & J, and a number of other major pharma companies, I think we've seen an extraordinary resurgence. Let's be honest. We

Science and Research committee  I can't resist pointing out how exciting it is that virtually every vaccine in the world has Canadian research based in it. Certainly when you look at the lipid nanoparticle technology that is centred in British Columbia with Dr. Pieter Cullis and others, it's very exciting for a

Science and Research committee  We're very proud of the program, specifically the executive institute. Candidly, this industry has a lot of work to do in identifying and promoting talent from gender equity-seeking groups. We deliberately said with that program that it would be fifty-fifty men and women and it w

Science and Research committee  I think it's certainly the case that we are seeing some of those. I would call them more of a nuisance than roadblocks. There are challenges in working through some of the visa situations. I can think anecdotally, like Dr. Mosca, of an example that we have right now of trying to

Science and Research committee  Thank you very much. I'm happy to be here this evening with my colleague, Dr. Youssef Bennani. We're here because Canada has an extraordinary research enterprise that punches well above its weight when measured against our competitors around the world. We're only now just beginn